Hypoplastic Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Hypoplastic Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure [Phase 1, Phase 2]
A NHLBI-sponsored Phase 1/2 trial is evaluating ruxolitinib, a JAK1/2 inhibitor, for relapsed/refractory immune bone marrow failure. The stu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis [Phase 2]
Phase 2 clinical trial evaluating haplo-identical transplantation with post-transplant cyclophosphamide for GVHD prophylaxis in severe aplas…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating unrelated umbilical cord blood transplantation using CordIn ex vivo expanded cells to accelerate engraft…